Fish Oil & Crohn’s Disease

Information provided by IcelandHealth.com

Crohn’s disease is a poorly understood inflammatory condition that affects the final part of the small intestine and the beginning section of the colon. It often causes bloody stools and malabsorption problems.

Dietary changes that may be helpful: A person with Crohn’s disease might consume more sugar than the average healthy person.1 A high-fiber, low-sugar diet led to a 79% reduction in hospitalizations compared with no dietary change in one group of people with Crohn’s disease.2 Another trial compared the effects of high- and low-sugar diets in people with Crohn’s disease.3 In that report, those with more active disease fared better on the low-sugar diet compared with those eating more sugar. Several people on the high-sugar diet had to stop eating sugar because their disease grew worse. While details of how sugar injures the intestine are still being uncovered, doctors often suggest eliminating all sugar (including soft drinks and processed foods with added sugar) from the diets of those with Crohn’s.

A high-animal-protein and high-fat diet (from foods other than fish) has been linked to Crohn’s disease in preliminary research.4 As with many other health conditions, it may be beneficial to eat less meat and dairy fat and more fruits and vegetables.

Some people with Crohn’s disease have food allergies and have been reported to do better when they avoid foods they are allergic to. One study found that people with Crohn’s are most likely to react to cereals, dairy, and yeast.5 Increasingly, baker’s yeast (found in bread and other bakery goods) has been implicated as a possible trigger for Crohn’s disease.6 Yeast and some cheeses are high in histamine, which is secreted during an allergenic response. People with Crohn’s disease lack the ability to break down histamine at a normal rate,7 so it is possible the link reported to yeast and dairy may not be coincidental.

In one trial, patients (rather than doctors) were asked which foods exacerbated Crohn’s symptoms.8 Those without ileostomies found nuts, raw fruit, and tomatoes to be most problematic, though responses varied from person to person, and other reports have come up with different lists.9 People with Crohn’s wishing to identify and avoid potential allergens should consult a doctor.

Lifestyle changes that may be helpful: People with Crohn’s disease are more likely to smoke, and there is evidence that continuing to smoke aggravates disease progression.10

Nutritional supplements that may be helpful: Crohn’s disease often leads to malabsorption. As a result, inadequate levels of many nutrients are common. For this reason, it makes sense for people with Crohn’s disease to take a high potency multiple vitamin/mineral supplement. In particular, deficiencies in zinc, folic acid, vitamin B12, vitamin D and iron have been reported.11 12 13 Zinc, folic acid, and vitamin B12 are needed to repair intestinal cells damaged by Crohn’s disease. Some doctors recommend 25–50 mg of zinc (balanced with 2–4 mg of copper), 800 mcg of folic acid, and 800 mcg of vitamin B12. Iron status should be evaluated by a doctor before considering supplementation.

Vitamin A is needed for the growth and repair of cells that line both the small and large intestine.14 Reports have appeared of people with Crohn’s responding to vitamin A.15 16 However, in one trial of 86 people with Crohn’s who were in remission, vitamin A supplementation for fourteen months led to no benefit.17 Therefore, although some doctors recommend 50,000 IU per day for adults with Crohn’s disease, this approach remains unproven. An amount this high should never be taken without qualified guidance, nor should it be given to a woman who is or could become pregnant.

Vitamin D malabsorption is common in Crohn’s18 and can lead to a deficiency.19 Successful treatment with vitamin D for osteomalacia (bone brittleness caused by vitamin D deficiency) triggered by Crohn’s disease has been reported.20 Another study found 1000 IU per day prevented bone loss in Crohn’s patients while an un-supplemented control group experienced significant bone loss.21 A doctor should evaluate vitamin D status and suggest the right level of vitamin D supplements.

Inflammation within the gut occurs in people suffering from Crohn’s. EPA and DHA, the omega-3 fatty acids found in Fish oil, have anti-inflammatory activity. A two-year trial compared the effects of having people with Crohn’s eat 3.5–7 ounces of fish high in EPA and DHA per day or a diet low in fish.22 In that trial, the fish-eating group had a 20% relapse rate compared with 58% in those not eating fish. Salmon, herring, mackerel, albacore tuna, and sardines are all high in EPA and DHA.

Supplementing 2.7 grams per day of a combination of EPA and DHA reduced the recurrence rate of Crohn’s disease at one year from 59% with placebo to 26% with Fish oil in a double-blind trial.23 This highly statistically significant improvement resulted from the use of a special enteric-coated, "free fatty acid" form of EPA/DHA taken from Fish oil. However, other blinded trials using other Fish oil supplements that are neither enteric-coated nor in the free-fatty-acid form have reported no clinical improvement.24 25 These disparate outcomes suggest the enteric-coated, free-fatty-acid form may have important advantages, including the reported ability to not cause gastrointestinal symptoms often resulting from taking regular Fish oil supplements.26

Diarrhea caused by Crohn’s disease has partially responded to Saccharomyces boulardii supplementation in double-blind research.27 Although the amount used in this trial—250 mg taken three times per day—was helpful, research successfully using Saccharomyces boulardii supplements with people suffering from other forms of diarrhea has used as much as 500 mg taken four times per day.28

Individuals with Crohn’s disease may be deficient in pancreatic enzymes, including lipase.29 In theory, supplemental enzymes might improve malabsorption associated with Crohn’s. People with Crohn’s disease considering supplementation with enzymes should consult a doctor.

Are there any side effects or interactions? Refer to the individual supplement for information about any side effects or interactions.

Herbs that may be helpful: Doctors sometimes use a combination of herbs to soothe inflammation throughout the digestive tract. The formula contains marshmallow, slippery elm, cranesbill, and several other herbs. Marshmallow and slippery elm are mucilaginous plants that help soothe inflamed tissues. Cranesbill is an astringent. Clinical trials using this combination have not been conducted.

A variety of anti-inflammatory herbs have historically been recommended by doctors for people with Crohn’s disease. These include yarrow, chamomile, licorice, and aloe juice. Cathartic preparations of aloe should be avoided. No research has been conducted to validate the use of these herbs for Crohn’s disease.

Tannin-containing herbs may be helpful to decrease diarrhea during acute flare-ups and have been used for this purpose in traditional medicine. An uncontrolled study using isolated tannins in the course of usual drug therapy found them more effective for reducing diarrhea than no additional treatment.30 Tannin-containing herbs of potential benefit include agrimony, green tea (also anti-inflammatory), oak, witch hazel, and cranesbill. Use of such herbs should be discontinued before the diarrhea is completely resolved, otherwise the disease could be exacerbated.

Are there any side effects or interactions? Refer to the individual herb for information about any side effects or interactions.

 

Checklist for Crohn’s Disease

Ranking

Nutritional Supplements

Herbs

Primary

Fish oil (enteric-coated, free-fatty-acid form)

Vitamin D

 

Secondary

Multiple vitamin/mineral (for prevention or treatment of deficiency only)

Saccharomyces boulardii

Zinc

 

Other

Lipase

Vitamin A

Aloe

Agrimony

Chamomile

Cranesbill

Green tea (also anti-inflammatory)

Licorice

Marshmallow

Oak

Slippery elm

Witch hazel

Yarrow

Information about the effects of a particular supplement or herb on a particular condition has been qualified in terms of the methodology or source of supporting data (for example: clinical, double blind, meta-analysis, or traditional use). For the convenience of the reader, the information in the table listing the supplements for particular conditions is also categorized. The criteria for the categorizations are: "Primary" indicates there are reliable and relatively consistent scientific data showing a health benefit. "Secondary" indicates there are conflicting, insufficient, or only preliminary studies suggesting a health benefit or that the health benefit is minimal. "Other" indicates that an herb is primarily supported by traditional use or that the herb or supplement has little scientific support and/or minimal proven health benefit.

[ Close Window ]

References:

1. Mayberry JF, Rhodes J. Epidemiological aspects of Crohn’s disease: a review of the literature. Gut 1984;886–99.

2. Heaton KW, Thornton JR, Emmett PM. Treatment of Crohn’s disease with an unrefined-carbohydrate, fibre-rich diet. BMJ 1979;2(6193):764–6.

3. Brandes JW, Lorenz-Meyer H. Sugar free diet: a new perspective in the treatment of Crohn disease? Randomized, control study. Z Gastroneterol 1981;19:1–12.

4. Shoda R, Masueda K, Yamato S, Umeda N. Epidemiologic analysis of Crohn’s disease in Japan: increased dietary intake of n-6 polyunsaturated fatty acids and animal protein relates to the increased incidence of Crohn’s disease in Japan. Am J Clin Nutr 1996;63:741–5.

5. Riordan AM, Hunter JO, Cowan RE, et al. Treatment of active Crohn’s disease by exclusion diet: East Anglian Multicentre Controlled Trial. Lancet 1993;342:1131–4.

6. Alic M. Baker’s yeast in Crohn’s disease-can it kill you? Am J Gastroenterol 1999;94:1711 [letter/review].

7. Wantke F, Gotz M, Jarisch R. Lancet 1994;343:113 [letter].

8. McDonald PJ, Fazio VW. What can Crohn’s patients eat? Eur J Clin Nutr 1988;42:703–8.

9. Gaby AR. Commentary. Nutr Healing January 1998, pp1,10–1 [review].

10. Cottone M, Rosselli M, Orlando A, et al. Smoking habits and recurrence in Crohn’s disease. Gastroenterol 1994;106:643–8.

11. Imes S, Plinchbeck BR, Dinwoodie A, et al. Iron, folate, vitamin B-12, zinc, and copper status in out-patients with Crohn’s disease: effect of diet counseling. J Am Dietet Assoc 1987;87:928–30.

12. Sandstead HH. Zinc deficiency in Crohn’s disease. Nutr Rev 1982;40:109–12.

13. Driscoll RH Jr, Meredith SC, Sitrin M, et al. Vitamin D deficiency and bone disease in patients with Crohn’s disease. Gastroenterology 1982;83:1252–8.

14. Dvorak AM. Vitamin A in Crohn’s disease. Lancet 1980;i:1303–4.

15. Skogh M, Sundquist T, Tagesson C. Vitamin A in Crohn’s disease. Lancet 1980; i:766 [letter].

16. Dvorak AM. Vitamin A in Crohn’s Disease. Lancet 1980;i:1303–4 [letter].

17. Wright JP, Mee AS, Parfitt A, et al. Vitamin A therapy inpatients with Crohn’s disease. Gastroenterology 1985;88:512–4.

18. Leichtmann GA, Bengoa JM, Bolt MJG, Sitrin MD. Intestinal absorption of cholecalciferol and 25-hydrocycholecalciferol in patients with both Crohn’s disease and intestinal resection. Am J Clin Nutr 1991;54:548–52.

19. Harris AD, Brown R, Heatley RV, et al. Vitamin D status in Crohn’s disease: association with nutrition and disease activity. Gut 1985;26:1197–203.

20. Driscoll RH, Meredith SC, Sitrin M, Rosenberg IH. Vitamin D deficiency and bone disease in patients with Crohn’s disease. Gastroenterol 1982;83:1252–8.

21. Vogelsang H, Ferenci P, Resch H, et al. Prevention of bone mineral loss in patients with Crohn’s disease by long-term oral vitamin D supplementation. Eur J Gastroenterol Hepatol 1995;7:609–14.

22. Mate J, Castanos R, Garcia-Samaniego J, Pajares JM. Does dietary fish oil maintain the remission of Crohn’s disease: a case control study. Gastroenterology 1991;100:A228 [abstract].

23. Belluzzi A, Brignola C, Campieri M, et al. Effect of an enteric-coated fish-oil preparation on relapses in Crohn’s disease. N Engl J Med 1996;334:1557–60.

24. Lorenz R, Weber PC, Szimnau P, et al. Supplementation with n-3 fatty acids from fish oil in chronic inflammatory bowel disease—a randomized, placebo-controlled, double-blind cross-over trial. J Intern Med Suppl 1989;225:225–32.

25. Lorenz-Meyer H, Bauer P Nicolay C, et al. Omega-3 fatty acids and low carbohydrate diet for maintenance of remission in Crohn’s disease. A randomized controlled multicenter trial. Study Group Members (German Crohn’s Disease Study Group). Scand J Gastroenterol 1996;31:778–85.

26. Belluzzi A, Brignola C, Campieri M, et al. Effects of new fish oil derivative on fatty acid phospholipid-membrane pattern in a group of Crohn’s disease patients. Dig Dis Sci 1994;39:2589–94.

27. Plein K, Hotz J. Therapeutic effects of Saccharomyces boulardii on mild residual symptoms in a stable phase of Crohn’s disease with special respect to chronic diarrhea—a pilot study. Z Gastroenterol 1993;31:129–34.

28. Bleichner G, Blehaut H, Mentec H, Moyse D. Saccharomyces boulardii prevents diarrhea in critically ill tube-fed patients. A muticenter, randomized, double-blind placebo-controlled trial. Intensive Care Med 1997;23:517–23.

29. Hegnhoj J, Hansen CP, Rannem T, et al. Pancreatic function in Crohn’s disease. Gut 1990;31:1076–9.

30. Plein K, Burkard G, Hotz J [Treatment of chronic diarrhea in Crohn disease. A pilot study of the clinical effect of tannin albuminate and ethacridine lactate] Fortschr Med 1993;( Mar 10) 111:114–8 [in German].

[ Close Window ]